South Africa confirms sale of unused Indian AstraZeneca vaccines finalised

South African Health Minister Zweli Mkhize has confirmed the sale of one million doses of the AstraZeneca coronavirus vaccine received from the Serum Institute of India last month has been concluded

AstraZeneca
AstraZeneca Covid-19 vaccine
Press Trust of India Johannesburg
2 min read Last Updated : Mar 22 2021 | 7:31 AM IST

South African Health Minister Zweli Mkhize has confirmed that the sale of one million doses of the AstraZeneca coronavirus vaccine received from the Serum Institute of India last month has been concluded.

The vaccines were sold to 14 African countries after South Africa suspended its planned usage to vaccinate healthcare workers when it was found to have limited efficacy against a new variant of the virus that became dominant in the country during a second wave of the pandemic towards the end of last year.

Instead, South Africa opted to use alternative vaccines to provide some level of immunity to thousands of healthcare workers, but concerns have been expressed over the slow rate of a planned three-phase vaccination programme amid delays in the delivery of vaccines.

"In the past weeks, the department has had to ensure that all member states identified by the African Union (AU) vaccine acquisition team as recipients of the vaccines are compliant and have obtained all regulatory approvals, permits and licenses to roll out the vaccines in their respective countries," Mkhize said in a statement released on Sunday.

Mkhize confirmed that the full purchase amount was received by the Department of Health on Monday last week. However, he did not disclose the amount.

"The AU and South African teams then ensured that all logistical arrangements are in place for the shipment of vaccines," the minister said.

The AU had found that the benefits of using the AstraZeneca vaccine, which has been suspended in a number of countries over safety fears, far outweighed the risks. The suspension came after reports of the vaccine causing blood clots in a few cases.

The first batch of vaccines was shipped to nine member states of the AU on Sunday, while the remaining will be collected by five other countries later this week.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAstraZenecaCoronavirus VaccineIndia-South Africa

First Published: Mar 22 2021 | 7:15 AM IST

Next Story